A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO
about
Guidelines by the AAPM and GEC-ESTRO on the use of innovative brachytherapy devices and applications: Report of Task Group 167.Air kerma and absorbed dose standards for reference dosimetry in brachytherapy.A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.Dependence with air density of the response of the PTW SourceCheck ionization chamber for low energy brachytherapy sources.Current state of the art brachytherapy treatment planning dosimetry algorithmsIn vivo dosimetry: trends and prospects for brachytherapy.Monte Carlo Dosimetry of the 60Co BEBIG High Dose Rate for BrachytherapyExperimental characterization of the dosimetric properties of a newly designed I-Seed model AgX100 ¹²⁵I interstitial brachytherapy sourceDosimetric verification of source strength for HDR afterloading units with Ir-192 and Co-60 photon sources: Comparison of three different international protocols.Physics-aspects of dose accuracy in high dose rate (HDR) brachytherapy: source dosimetry, treatment planning, equipment performance and in vivo verification techniquesOn the use of a single-fiber multipoint plastic scintillation detector for 192Ir high-dose-rate brachytherapyDosimetric impact of an air passage on intraluminal brachytherapy for bronchus cancerTherapeutic analysis of high-dose-rate (192)Ir vaginal cuff brachytherapy for endometrial cancer using a cylindrical target volume model and varied cancer cell distributions.New (125)I brachytherapy source IsoSeed I25.S17plus: Monte Carlo dosimetry simulation and comparison to sources of similar design.Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPMA brief look at model-based dose calculation principles, practicalities, and promiseEffect of tissue composition on dose distribution in brachytherapy with various photon emitting sources.Anode optimization for miniature electronic brachytherapy X-ray sources using Monte Carlo and computational fluid dynamic codes.Microfocus x-ray imaging of traceable pointlike 22 Na sources for quality control.Comparison of 192 Ir, 169 Yb, and 60 Co high-dose rate brachytherapy sources for skin cancer treatment.Quantitative evaluation of patient setup uncertainty of stereotactic radiotherapy with the frameless 6D ExacTrac system using statistical modeling.A directional 103Pd brachytherapy device: Dosimetric characterization and practical aspects for clinical use.Film based verification of calculation algorithms used for brachytherapy planning-getting ready for upcoming challenges of MBDCA.Monte Carlo dosimetry of the IRAsource high dose rate (192)Ir brachytherapy source.Episcleral eye plaque dosimetry comparison for the Eye Physics EP917 using Plaque Simulator and Monte Carlo simulation.A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.A revised dosimetric characterization of the model S700 electronic brachytherapy source containing an anode-centering plastic insert and other components not included in the 2006 model.Measurement uncertainty analysis of low-dose-rate prostate seed brachytherapy: post-implant dosimetry.Dosimetric characterization of two radium sources for retrospective dosimetry studies.Testicular shielding in penile brachytherapyA Monte Carlo evaluation for effects of probable dimensional uncertainties of low dose rate brachytherapy seeds on dose.Optically stimulated luminescent dosimetry for high dose rate brachytherapy.Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.Comparison of methods for the measurement of radiation dose distributions in high dose rate (HDR) brachytherapy: Ge-doped optical fiber, EBT3 Gafchromic film, and PRESAGE® radiochromic plastic.In vivo measurements for high dose rate brachytherapy with optically stimulated luminescent dosimeters.Response of LiF:Mg,Ti thermoluminescent dosimeters at photon energies relevant to the dosimetry of brachytherapy (<1 MeV).Measurement of absorbed dose-to-water for an HDR (192)Ir source with ionization chambers in a sandwich setup.Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET.I-125 ROPES eye plaque dosimetry: validation of a commercial 3D ophthalmic brachytherapy treatment planning system and independent dose calculation software with GafChromic® EBT3 films.Dosimetric impact of cylinder size in high-dose rate vaginal cuff brachytherapy (VCBT) for primary endometrial cancer.
P2860
Q30151984-96E82717-CB28-42FD-9316-C1A5CCFE1909Q30403620-039143CF-2570-47CF-B15A-4E131E633298Q30751737-DF43E21F-7C67-4964-9D56-0FAB2F312054Q33460233-DBACEEAB-2B2E-48EB-B73A-7ED5726AF6CEQ35676743-1A12F0D9-7405-4C7E-8237-DE0C575DBAF3Q35676752-0AD2FB37-57EA-4702-A7CA-BC1F73CDC1F9Q35791947-ABD3C5B5-2243-4CF7-A10F-31A7DBF51272Q35899022-56717A5E-0250-4E83-8300-3EC4732958ECQ36495303-0EF5769C-574F-4C79-B08C-8DB4EAAC0AE8Q36555599-F94B8D3D-FFA4-4DB8-BC57-165CAD617E11Q36874569-3A14106D-45BE-4D7D-8F26-2E6EDDA42EF1Q37472685-CCBBCC5B-0168-4E93-B711-9C81C6EB6340Q37490275-D53DBA7E-FFFE-4057-8066-E8E271F06693Q37506997-38FEB3F0-2324-4294-A2D9-E8FB4CE1E533Q37672269-F89D3A74-8262-40CE-8F21-790569493B29Q37694566-A0B64B54-EC60-4232-991D-2A587B428DB1Q37730048-D7C9523D-84D7-40D7-BC04-A046DB9F54A9Q38635112-AEE5BCCD-AA86-4C04-80EF-9ECF6AEABF39Q38779258-EA10E0A3-C65E-4D78-B08E-96B174BE9F84Q38791975-A8FC9195-D303-4E72-9429-CF009FDEA60EQ38905780-E5F01F3E-9AB9-40D1-8ACF-74437DBF0C02Q39049492-B9CCE5F2-AB7B-465C-B41D-9B1142418C2FQ39371951-D46AD489-2201-40CA-B8EC-F3A6DC85EDCCQ39975820-43A52E4C-1872-433E-B93D-4A56919383BDQ40176373-0B05B565-F501-4A04-9653-A19CD72CE7CBQ40780870-0EDEF8AB-BDE5-49C0-9851-934B2BF0CF07Q40780942-B8ADA776-698B-41F4-B91D-1008410724B9Q41630165-3EE7BADA-0F8D-4AE1-B69D-4AD9FEF3CE41Q41735676-702E90DC-3503-4D83-9B0F-62E0ED5B9954Q41788587-10FED0B4-225B-458D-99EC-DBEF48D332E6Q42149267-646E8317-6BBF-472F-B59B-C102FF707D09Q42198711-28F4C972-4623-4C96-8B3A-C492D487FD69Q43805641-040EA45C-5E4D-4C0E-A077-40C0000AF3A4Q43913936-BCA34686-1B6F-424C-A79A-6194D303C917Q44086699-ED7096CF-762A-42D1-A218-45BA076DA03BQ44123384-B6F3AAD7-F174-42DA-982B-B6F56B4C1EB2Q45785367-0C99A0F1-02F2-4B92-A557-9A3E547D1651Q46086497-5114A712-AD22-4EBB-A22C-54A137D9ADA0Q46747884-E3DB020D-33D8-4BF4-AA88-00B438CBC574Q47270650-C90D8629-4E5A-49F4-81C1-3C8B8FB923A9
P2860
A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A dosimetric uncertainty analy ...... sk Group No. 138 and GEC-ESTRO
@ast
A dosimetric uncertainty analy ...... sk Group No. 138 and GEC-ESTRO
@en
A dosimetric uncertainty analy ...... sk Group No. 138 and GEC-ESTRO
@nl
type
label
A dosimetric uncertainty analy ...... sk Group No. 138 and GEC-ESTRO
@ast
A dosimetric uncertainty analy ...... sk Group No. 138 and GEC-ESTRO
@en
A dosimetric uncertainty analy ...... sk Group No. 138 and GEC-ESTRO
@nl
prefLabel
A dosimetric uncertainty analy ...... sk Group No. 138 and GEC-ESTRO
@ast
A dosimetric uncertainty analy ...... sk Group No. 138 and GEC-ESTRO
@en
A dosimetric uncertainty analy ...... sk Group No. 138 and GEC-ESTRO
@nl
P2093
P2860
P356
P1433
P1476
A dosimetric uncertainty analy ...... sk Group No. 138 and GEC-ESTRO
@en
P2093
Ali S Meigooni
Bruce R Thomadsen
Geoffrey S Ibbott
Jack L M Venselaar
Kurt E Stump
Larry A DeWerd
Mark J Rivard
Michael G Mitch
P2860
P304
P356
10.1118/1.3533720
P407
P577
2011-02-01T00:00:00Z